Formulation Development
CDRI develops pharmaceutical formulations
across all phases of clinical development, ranging from preclinical to
late-stage trials.
Preformulation Studies
- Definition of target product profile
- Physicochemical property characterization
- Compatibility studies between APIs and excipients
- Solubility enhancement and bioavailability improvement
Formulation and Process Development
- Development of solutions, suspensions, tablets, and capsules
- Application of direct compression, encapsulation, dry/wet granulation techniques
- Modified-release dosage forms (e.g., matrix tablets, enteric coatings, multiparticulates)
- Process optimization utilizing Quality by Design (QbD) and Design of Experiments (DoE) principles
